| 摘要 |
<p>The present invention is related to a pharmaceutical composition that comprises the synergistic combination of an anti-arthritic agent, such as Chondroitin sulfate as active principle; a chondroprotecting agent, such as Glucosamine as active principle, and an anti-inflammatory agent such as Meloximam as active principle, which are formulated in the form of an orally administered single dosage unit in a powder solution, available in monodose sachets useful for treating diseases such as: Osteoarthritis, rheumatoid arthritis, arthrosis and any other related rheumatic disease.</p> |
